Brand-name tirzepatide auto-injector pens from Eli Lilly. The same dual-action GLP-1/GIP medication as Zepbound — in a 4-pen monthly box with all five doses available.
4-pen box, all doses. Includes provider consultation, prescription, and free cold-chain shipping.
Start your consultationMounjaro contains the same active ingredient (tirzepatide) as Zepbound. Originally approved for type 2 diabetes, widely prescribed for weight management.
Zepbound targets both GLP-1 and GIP receptors — the only FDA-approved dual-action weight loss medication available. Clinical trials showed patients losing an average of 20% of their body weight.
Targets both GLP-1 and GIP receptors for more effective appetite control than single-target medications.
Fully reviewed and approved by the FDA for chronic weight management in adults with obesity or overweight.
Significantly reduces appetite and food cravings, making it easier to maintain a calorie deficit naturally.
Clinical trials demonstrated an average of 20.9% body weight loss over 72 weeks when combined with diet and exercise.
One simple injection per week via the easy-to-use KwikPen. No mixing, no vials, no complicated dosing.
Improves blood sugar regulation and supports overall metabolic health beyond just weight loss.
Your $299/month includes everything — the medication, your provider consultation, ongoing care, and shipping. No membership fees, no hidden charges.
Brand-name, factory-sealed tirzepatide injection pen. Available in all six FDA-approved doses.
Licensed medical provider reviews your health profile and prescribes the right dose for you.
Message your provider anytime through your patient portal. Dose adjustments handled seamlessly.
Cold-chain shipping ensures your medication arrives safely. Discreet packaging, delivered to your door.
Mounjaro® is manufactured by Eli Lilly and dispensed through licensed US pharmacies. Every unit is factory-sealed and verified.
Fully approved by the FDA for chronic weight management in adults.
Brand-name 4-pen box from Eli Lilly. Not compounded. Not modified.
Dispensed by a licensed US pharmacy within our verified network.
Shipped with temperature monitoring to ensure medication integrity.
Answer a few health questions online. Takes about 5 minutes. No appointment needed.
A licensed medical provider evaluates your health history and determines if Zepbound is right for you.
Once approved, your Mounjaro pens ship via cold-chain delivery within 3-5 business days.
Mounjaro (tirzepatide) is an FDA-approved dual-action GLP-1/GIP receptor agonist from Eli Lilly. Originally approved for type 2 diabetes, it is widely used for weight management. Delivered as a 4-pen monthly auto-injector box.
Same active ingredient (tirzepatide) from Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is FDA-approved for weight management. The medication is identical — the difference is the approved indication and pen format.
Five doses available: 2.5mg, 5mg, 7mg, 10mg, and 12.5mg. Each box contains 4 pre-filled pens (one month supply). Your provider titrates based on response.
Direct pharmacy partnership pricing. Mounjaro 4-pen boxes at competitive rates with provider consultation and cold-chain shipping included.
No. CLYR's pricing includes everything — medication, provider consultation, and shipping. No insurance needed, no copays, no prior authorizations. One transparent price.
If your provider determines that Zepbound is not appropriate for you, you will not be charged. You'll be notified with an explanation and may be offered alternative treatment options.
Complete your free consultation in 5 minutes. If approved, your medication ships within days.
Get started today